Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150 participants
OBSERVATIONAL
2022-09-26
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Growth hormone (GH) is secreted in a pulsatile manner with maximum peaks primarily at night, raising questions about the relationship between sleep disturbances and short stature.
In children, one of the main causes of sleep disturbances in the digital age is screen use, which is becoming increasingly important, particularly in the pediatric population.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnosis of Short Stature in Children : Study of a Cohort of Small-sized Consulting Patients
NCT04754516
Pharmacodynamics of CNP During Growth Hormone Treatment
NCT01504802
Growth Retardation In Children With Special Pathological Conditions Or Disease
NCT00163215
Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin
NCT00488124
GH and Cardiovascular Risk Factors
NCT01877512
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
While many studies have examined the impact of screens on children's psychological balance, weight, etc., none, to our knowledge, has examined the potential impact of screens on children's height growth. Hypothesis of this project: 70% of GH synthesis takes place at night, a few minutes after entering slow-wave sleep, sleep disturbed by screens could mean a lower secretion of GH and consequently a delay in height growth.
The objective of this project is to evaluate the impact of screen consumption on sleep and the impact of sleep on idiopathic growth disorder.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Growth hormone stimulation test group
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Not opposed to participating in the study
* Patients affiliated with the Social Security system
Exclusion Criteria
* Hypothyroidism
* Hypercorticism
* All chronic diseases
* Skeletal pathologies: Turner syndrome, constitutional bone disease Intrauterine growth retardation
* Pubertal delay defined by absence of puberty onset \>13 years in girls and 14 years in boys
* Patient under guardianship
6 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Rouen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mireille MC CASTANET, Professor
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Rouen
Mireille MC CASTANET, Professor
Role: STUDY_DIRECTOR
University Hospital, Rouen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Rouen
Rouen, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID RCB : 2021-A01115-36
Identifier Type: OTHER
Identifier Source: secondary_id
2021/138/OB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.